Skip to content
Clinical Trials – home
EstoniaBack to Estonia

Clinical trials in Mustamae Linnaosa – page 11

159 clinical trials in Mustamae Linnaosa, Estonia. Every trial is listed in the EU Clinical Trials Register and updated daily.

EstoniaOur site in EstoniaKliinilisedUuringud.ee(opens in a new tab)
Mustamae Linnaosa at a glance
159
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

159 trials in Mustamae Linnaosa

Open in trial search

Rheumatoid arthritis

Not recruiting

Study on Rosnilimab for Patients with Moderate to Severe Rheumatoid Arthritis

Investigational
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Rosnilimab
  • Sponsor:Anaptysbio Inc.

Study of V940 and Pembrolizumab for Patients with Resected Stage II, IIIA, IIIB Non-Small Cell Lung Cancer

Registered drug
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:MRNA-4157
  • Sponsor:Merck Sharp & Dohme LLC

Plasma cell myeloma

Not recruiting

Study on the Effectiveness of Talquetamab and Teclistamab in First-Line Treatment for Transplant-Eligible Multiple Myeloma Patients

Registered drugNo placebo
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:North Estonia Medical Centre Foundation

Study on Aprepitant for Preventing Nausea and Vomiting After Bariatric Surgery in Patients

Registered drug
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Aprepitant
  • Sponsor:University Of Tartu

Long-Term Study of BI 1015550 for Patients with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis

InvestigationalNo placebo
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Nerandomilast
  • Sponsor:Boehringer Ingelheim Espana S.A.

Adenocarcinoma gastric+1

Not recruiting

Study of Pembrolizumab with Chemotherapy for Patients with Gastric or Gastroesophageal Junction Cancer

Registered drug
Countries:EstoniaEstonia
  • Participants:18–64 years
  • Substances:Calcium Folinate
  • Sponsor:Merck Sharp & Dohme LLC

Study Comparing Crovalimab and Eculizumab for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently on Complement Inhibitors

Registered drugNo placebo
Countries:EstoniaEstonia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Crovalimab
  • Sponsor:F. Hoffmann-La Roche AG

Crohn's disease

Not recruiting

Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn's Disease

Investigational
Countries:EstoniaEstonia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study of Pembrolizumab for Patients with Early Stage Non-Small Cell Lung Cancer After Surgery and Standard Therapy

Registered drug
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Merck Sharp & Dohme LLC

Study on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis

Registered drug
Countries:EstoniaEstonia
  • Participants:18–64 years
  • Substances:Charcoal, Activated
  • Sponsor:Novartis Pharma AG

Hypercholesterolaemia

Not recruiting

Study on Inclisiran and Rosuvastatin for Lowering Cholesterol in Patients with High Cholesterol Levels

Registered drug
Countries:EstoniaEstonia
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG

Multiple sclerosis

Not recruiting

Study on Long-Term Safety and Efficacy of Ocrelizumab for Patients with Multiple Sclerosis

Registered drugNo placebo
Countries:EstoniaEstonia
  • Participants:18–64 years
  • Substances:Ocrelizumab
  • Sponsor:F. Hoffmann-La Roche AG

Other cities in Estonia

The busiest research cities in the country

All 10 cities in Estonia

Clinical research in Mustamae Linnaosa

What the registry says about research in the country

01 Oncology Research

Clinical studies focusing on darolutamide treatment for cancer patients, alongside groundbreaking research in esophageal carcinoma treatment combining chemoradiotherapy with innovative therapeutic approaches.

  • Cancer Treatment Continuity
  • Esophageal Cancer Therapy
  • Treatment Safety Evaluation

These trials aim to advance cancer treatment options and improve patient outcomes through targeted therapies.

02 Infectious Diseases

Innovative research examining the effectiveness of ceftolozane/tazobactam in treating pediatric patients with nosocomial pneumonia, focusing on safety profiles and treatment responses.

  • Hospital-Acquired Pneumonia
  • Pediatric Treatment Solutions
  • Antibiotic Safety Studies

These studies aim to enhance treatment options for young patients with hospital-acquired infections.

03 Hematology & Rheumatology

Comprehensive research programs investigating treatments for Acute Lymphoblastic Leukaemia in young patients and evaluating upadacitinib for rheumatoid arthritis management.

  • Leukemia Treatment in Young Patients
  • Rheumatoid Arthritis Therapy
  • Immunotherapy Advances

These trials focus on improving survival rates and quality of life for patients with blood disorders and autoimmune conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.